Swiss gene editing company CRISPR Therapeutics and US-based Vertex Pharmaceuticals have started treating patients in a Phase I/II clinical trial...
Read more
Shimmer, a global leader in wearable technology for research applications, announced the launch of Verisense, its next-generation wearable sensor platform...
Read more
Boehringer Ingelheim and IBM Canada announced at the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida, their...
Read more
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases announced its plans to initiate...
Read more
Bluebird bio, Inc. and Celgene Corporation announced initial data from the ongoing Phase 1 clinical study of bb21217 (CRB-402), an...
Read more
QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, announced the expansion of its U.S.-based...
Read more
AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing...
Read more
AMAL Therapeutics SA , a Swiss biotech developing peptide-based therapeutic cancer vaccines, announces that it has completed the second closing...
Read more
Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable medical devices, announced that it has initiated enrollment of patients...
Read more
Immutep Limited is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
